FinVector

FinVector is a cGMP manufacturer of viral-based gene therapy products, based in the Savilahti science and technology district of Kuopio, Finland. The company describes itself as a leading cGMP manufacturer of viral-based products and states that it produces a treatment for Non-Muscle Invasive Bladder Cancer. It also states that its experience in drug discovery science and manufacturing practices spans over 30 years.

FinVector states that its extensive experience in drug discovery science and manufacturing practices spans over 30 years. The company operates a high-tech manufacturing facility in the Savilahti science and technology district of Kuopio, Finland, and describes itself as a cGMP manufacturer of viral-based gene therapy products. It states that it presently produces a treatment for Non-Muscle Invasive Bladder Cancer.

cGMP manufacturer of viral-based gene therapy products; described as a beacon of innovation in the cancer drug industry and a leader in viral-based gene therapy product manufacturing.

• Viral-based gene therapy products

  cGMP-manufactured viral-based gene therapy products.

• Treatment for Non-Muscle Invasive Bladder Cancer

  A groundbreaking treatment for Non-Muscle Invasive Bladder Cancer that FinVector states it presently produces.

1. 1Finvector | Embracing life. Delivering hope.finvector.com
2. 2About Us | FinVector - Our Inspiring Journey | Finvectorfinvector.com